The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set

Ying Ying Leung; Ana-Maria Orbai; Alexis Ogdie; Laura C Coates; Maarten de Wit; Lihi Eder; Dafna D Gladman; Niti Goel; Philip J Mease; Vibeke Strand; Oliver FitzGerald; William Tillett

doi:10.3899/jrheum.190122

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set

Ying Ying Leung, Ana-Maria Orbai, Alexis Ogdie, Laura C Coates, Maarten de Wit, Lihi Eder, Dafna D Gladman, Niti Goel, Philip J Mease, Vibeke Strand, Oliver FitzGerald, William Tillett

Department of Life Sciences

Research output: Contribution to journal › Article › peer-review

14 Citations (SciVal)

15 Downloads (Pure)

Abstract

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Working Group reported at the 2018 GRAPPA annual meeting on the outcome of the OMERACT 2018 Conference in Terrigal, Australia. The working group presented the endorsement of the 66/68 joint count for the assessment of peripheral arthritis and the provisional endorsement of the PsA Impact of Disease 12 questionnaire for the assessment of PsA-specific health-related quality of life in PsA randomized controlled trials and observational studies. In this report, the group presents its plan to seek OMERACT endorsement for outcome measures that address the domains of MSK disease activity for enthesitis and dactylitis, physical function, fatigue, and structural damage following the OMERACT Filter 2.1 methodology.

Original language	English
Pages (from-to)	33-37
Number of pages	5
Journal	The Journal of rheumatology. Supplement
Volume	95
DOIs	https://doi.org/10.3899/jrheum.190122
Publication status	Published - 1 Jun 2019

Access to Document

10.3899/jrheum.190122

6--Orbai--The GRAPPA-OMERACT PSA Core Outcome Measures--Second-edited draft
This is a pre-copyediting, author-produced PDF of an article accepted for publication in The Journal of Rheumatology Supplement following peer review. The definitive publisher-authenticated version Ying Ying Leung, Ana-Maria Orbai, Alexis Ogdie, Laura C. Coates, Maarten de Wit, Kristina Callis Duffin, Lihi Eder, Dafna D. Gladman, Niti Goel, Philip J. Mease, Vibeke Strand, Oliver FitzGerald and William Tillett The Journal of Rheumatology Supplement June 2019, 95 33-37; DOI: https://doi.org/10.3899/jrheum.190122 is available online at: http://www.jrheum.org/content/95/33.tab-article-info
Accepted author manuscript, 78.3 KBLicence: Unspecified

Outcome Measures for Randomised Controlled Trials in Psoriatic Arthritis
Tillett, W. (PI)
1/09/16 → 3/07/20
Project: Central government, health and local authorities

Cite this

Leung, Y. Y., Orbai, A.-M., Ogdie, A., Coates, L. C., de Wit, M., Eder, L., Gladman, D. D., Goel, N., Mease, P. J., Strand, V., FitzGerald, O., & Tillett, W. (2019). The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set. The Journal of rheumatology. Supplement, 95, 33-37. https://doi.org/10.3899/jrheum.190122

Leung, YY, Orbai, A-M, Ogdie, A, Coates, LC, de Wit, M, Eder, L, Gladman, DD, Goel, N, Mease, PJ, Strand, V, FitzGerald, O & Tillett, W 2019, 'The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set', The Journal of rheumatology. Supplement, vol. 95, pp. 33-37. https://doi.org/10.3899/jrheum.190122

@article{e2c8665d9e8d46b49c82912d204f10e9,

title = "The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set",

abstract = "The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Working Group reported at the 2018 GRAPPA annual meeting on the outcome of the OMERACT 2018 Conference in Terrigal, Australia. The working group presented the endorsement of the 66/68 joint count for the assessment of peripheral arthritis and the provisional endorsement of the PsA Impact of Disease 12 questionnaire for the assessment of PsA-specific health-related quality of life in PsA randomized controlled trials and observational studies. In this report, the group presents its plan to seek OMERACT endorsement for outcome measures that address the domains of MSK disease activity for enthesitis and dactylitis, physical function, fatigue, and structural damage following the OMERACT Filter 2.1 methodology.",

author = "Leung, {Ying Ying} and Ana-Maria Orbai and Alexis Ogdie and Coates, {Laura C} and {de Wit}, Maarten and Lihi Eder and Gladman, {Dafna D} and Niti Goel and Mease, {Philip J} and Vibeke Strand and Oliver FitzGerald and William Tillett",

year = "2019",

month = jun,

day = "1",

doi = "10.3899/jrheum.190122",

language = "English",

volume = "95",

pages = "33--37",

journal = "The Journal of rheumatology. Supplement",

issn = "0380-0903",

publisher = "Journal of Rheumatology",

}

TY - JOUR

T1 - The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting

T2 - Report and Plan for Completing the Core Outcome Measurement Set

AU - Leung, Ying Ying

AU - Orbai, Ana-Maria

AU - Ogdie, Alexis

AU - Coates, Laura C

AU - de Wit, Maarten

AU - Eder, Lihi

AU - Gladman, Dafna D

AU - Goel, Niti

AU - Mease, Philip J

AU - Strand, Vibeke

AU - FitzGerald, Oliver

AU - Tillett, William

PY - 2019/6/1

Y1 - 2019/6/1

N2 - The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Working Group reported at the 2018 GRAPPA annual meeting on the outcome of the OMERACT 2018 Conference in Terrigal, Australia. The working group presented the endorsement of the 66/68 joint count for the assessment of peripheral arthritis and the provisional endorsement of the PsA Impact of Disease 12 questionnaire for the assessment of PsA-specific health-related quality of life in PsA randomized controlled trials and observational studies. In this report, the group presents its plan to seek OMERACT endorsement for outcome measures that address the domains of MSK disease activity for enthesitis and dactylitis, physical function, fatigue, and structural damage following the OMERACT Filter 2.1 methodology.

AB - The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Working Group reported at the 2018 GRAPPA annual meeting on the outcome of the OMERACT 2018 Conference in Terrigal, Australia. The working group presented the endorsement of the 66/68 joint count for the assessment of peripheral arthritis and the provisional endorsement of the PsA Impact of Disease 12 questionnaire for the assessment of PsA-specific health-related quality of life in PsA randomized controlled trials and observational studies. In this report, the group presents its plan to seek OMERACT endorsement for outcome measures that address the domains of MSK disease activity for enthesitis and dactylitis, physical function, fatigue, and structural damage following the OMERACT Filter 2.1 methodology.

U2 - 10.3899/jrheum.190122

DO - 10.3899/jrheum.190122

M3 - Article

C2 - 31154402

SN - 0380-0903

VL - 95

SP - 33

EP - 37

JO - The Journal of rheumatology. Supplement

JF - The Journal of rheumatology. Supplement

ER -

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set

Abstract

Access to Document

Fingerprint

Projects

Outcome Measures for Randomised Controlled Trials in Psoriatic Arthritis

Cite this